Robert Rubin

Questcor Pharmaceuticals, Inc. was engaged in development, marketing and sale of prescription drugs. It operated as a biopharmaceutical company which focuses on the treatment of patients with serious, difficult-to-treat autoimmune and inflammatory disorders. The company's primary product was H.P. Acthar Gel, an injectable drug for the treatment of proteinuria in the nephrotic syndrome of the idiopathic type, or NS, the treatment of acute exacerbations of multiple sclerosis, or MS, in adults, the treatment of infantile spasms, or IS, in infants and children under two years of age, and the treatment of certain rheumatology related conditions, including the treatment of the rare and closely related neuromuscular disorders dermatomyositis and polymyositis. Questcor Pharmaceuticals was founded in September 1992 and was headquartered in Anaheim, CA.

Part of The Cigna Group, Valuerx, Inc. is an American company that provides pharmacy benefit management services. The company is based in TN. Valuerx was acquired by Express Scripts, Inc., a subsidiary of The Cigna Group from Columbia/HCA Healthcare Corp. on April 01, 1998 for $445 million.

Lewin-VHI, Inc. is a private company based in Fairfax, VA.

Part of HCA Healthcare, Inc., Lewin-ICF, Inc. is a health policy consultant. The company is based in Fairfax, VA. Lewin-ICF was acquired by Value Health, Inc. from Kaiser Group Holdings, Inc. on December 03, 1992.

ICF, Inc. manufactures and markets cleaning and drying machinery for semiconductors.

The Lewin Group, Inc. operates as a health care and human services consulting firm. Its services include modeling, statistics, and actuarial analysis, policy research and data analysis, program effectiveness, strategic planning, and technical assistance. The company was founded by Lawrence S. Lewin in 1970 and is headquartered in Falls Church, VA.

BioTelemetry, Inc. provides monitoring services and digital population health management in a healthcare setting, medical device manufacturing and centralized core laboratory services for clinical research. The firm also develops proprietary integrated patient management platform that incorporates wireless data transmission network. It operates through the following segments: Healthcare, and Research. The Healthcare segment is focused on the diagnosis and monitoring of cardiac arrhythmias or heart rhythm disorders. The Research segment is engaged in central core laboratory services providing cardiac monitoring, imaging services, scientific consulting and data management services for drug and medical device trials. The company was founded on April 22, 2013 and is headquartered in Malvern, PA.